The BT-1000 is an electroceutical device developed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), a common neurodevelopmental disorder affecting children. ADHD can lead to difficulty in focusing, impulsive behavior, and hyperactivity, impacting academic performance and social interactions.
The BT-1000 is a prescription medical device that delivers electrical stimulation through two forehead electrodes. These electrodes, composed of a divided anode and cathode, allow for diverse and selective stimulation pathways. By targeting specific brain regions, the device may help regulate neural activity associated with ADHD symptoms, improving focus, impulse control, and behavioral stability.
Children with ADHD often exhibit:
The BT-1000 offers a non-invasive approach to ADHD treatment, providing an alternative or complementary therapy alongside behavioral interventions or medication. Through targeted neurostimulation, the device may help enhance attention, reduce hyperactivity, and improve impulse regulation, supporting children in achieving better behavioral control.
As an innovative electroceutical device, the BT-1000 provides a safe, effective, and targeted solution for managing ADHD symptoms. With its dual-electrode design, selective stimulation pathways, and user-friendly application, it represents a promising advancement in neurostimulation therapy, helping children improve focus, impulse control, and overall quality of life.
The person in charge
Kyungho KimAddress
39 Deoksan-ro, Hanam-si, Gyeonggi-do (12981)큐알
Please enter the text on the left image to prevent automatic input.
0 / 4000
PLATINUM